Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects
- 1 May 1995
- journal article
- research article
- Published by Wiley in Teratology
- Vol. 51 (5), 311-317
- https://doi.org/10.1002/tera.1420510507
Abstract
The role of folic acid in the primary prevention of neural tube defects (NTDs) is well established. However, questions related to the protective mechanism remain unanswered. To help answer these questions, we designed a case‐control study to assess the role of folate‐and cobalamin‐related metabolites in the pathogenesis of NTDs. Concentrations of folate, cabalamin, and 14 other related metabolites were measured by gas chromatography/mass spectrometry in midtrimester serum specimens from 32 women with an NTD‐affected pregnancy and from 132 control women, and in serum specimens from 46 nonpregnant women who had a history of NTD‐affected pregnancy and from 43 nonpregnant control women. Log‐transformed means of metabolites were compared between case and control women for both the midtrimester and nonpregnant groups. In the pregnant group, serum methylmalonic acid (MMA) concentrations were higher among case women than among control women (130 vs 105 nM). There was a strong dose‐response relationship between midtrimester serum MMA level and the risk for an NTD‐affected pregnancy, with the relative risk increasing 13‐fold for women with MMA levels>90th percentile. In the nonpregnant group, there was no difference in serum MMA levels between case and control women (140 vs 140 nM). Thus, the serum MMA levels of women in the midtrimester of pregnancies unaffected by NTDs were significantly lower than the levels of nonpregnant women, whereas the levels of women whose pregnancies were affected by NTDs were similar to those of nonpregnant women. The finding of elevated MMA serum concentrations among women in the midtrimester of NTD‐affected pregnancies suggests that cobalamin may be involved in the etiology of NTDs. The possible role of cobalamin in relation to the protective effect of folic acid needs further evaluation. © 1995 Wiley‐Liss, Inc. 1 This article is a US Government work and, as such, is in the public domain in the United States of America .Keywords
This publication has 35 references indexed in Scilit:
- Possible Abnormalities of Folate and Vitamin B12 Metabolism Associated with Neural Tube DefectsaAnnals of the New York Academy of Sciences, 1993
- Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin SupplementationNew England Journal of Medicine, 1992
- Maternal vitamin levels during pregnancies producing infants with neural tube defectsThe Journal of Pediatrics, 1992
- Prevention of neural tube defects: Results of the Medical Research Council Vitamin StudyThe Lancet, 1991
- The effect of periconceptional supplementation on blood vitamin concentrations in women at recurrence risk for neural tube defectBritish Journal of Nutrition, 1983
- Amniotic fluid and maternal serum amino acid levels in malformations of fetal central nervous systemNeurochemical Research, 1980
- VITAMIN B12 AND ANENCEPHALYThe Lancet, 1980
- FOLATES AND THE FETUSThe Lancet, 1977
- FOLIC ACID DEFICIENCY AND CONGENITAL MALFORMATIONBJOG: An International Journal of Obstetrics and Gynaecology, 1972
- SERUM VITAMIN B12 LEVELS IN PREGNANT WOMENBJOG: An International Journal of Obstetrics and Gynaecology, 1968